Efficacy and Safety of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Disease: An Updated Systemic Review and Meta-Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Disease: An Updated Systemic Review and Meta-Analysis

Published:2023-12-31 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

El-Atawi Khaled,De Luca Daniele,Ramanathan Ranagasamy,Sanchez Luna Manuel,Alsaedi Saad,Abdul Wahab Muzafar Gani,Hamdi Moataz,Saleh Maysa

Publisher

Springer Science and Business Media LLC

Subject

Aerospace Engineering

Reference36 articles.

1. Respiratory syncytial virus infection: an illness for all ages;Walsh EE;Clin Chest Med,2017

2. Respiratory syncytial virus: infection, detection, and new options for prevention and treatment;Griffiths C;Clin Microbiol Rev,2017

3. Evidence for a causal relationship between respiratory syncytial virus infection and asthma;Wu P;Expert Rev Anti Infect Ther,2011

4. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection;Thorburn K;Arch Dis Child,2009

5. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis;Robinson KA;Cochrane Database Syst Rev,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection;Expert Review of Anti-infective Therapy;2024-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP